Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

[Cardiovascular risk by Framingham and SCORE in patients 40-65 years old].

González C, Rodilla E, Costa JA, Justicia J, Pascual JM.

Med Clin (Barc). 2006 Apr 15;126(14):527-31. Spanish.

PMID:
16756903
2.

[The application of the SCORE charts to advanced age males triple the number of high-risk subjects compared to the Framingham function].

Mostaza JM, Vicente I, Taboada M, Laguna F, Echániz A, García-Iglesias F, Lahoz C.

Med Clin (Barc). 2005 Apr 9;124(13):487-90. Spanish.

PMID:
15847765
3.

Agreement between Framingham-DORICA and SCORE scales in estimation of cardiovascular risk in the patients suffering from metabolic syndrome in Granada (Spain).

Ruiz-Villaverde G, Sánchez-Cano D, Ruiz-Villaverde R, Abalos-Medina GM, Ramírez-Rodrigo J, Villaverde-Gutiérrez C.

Ir J Med Sci. 2011 Jun;180(2):351-4. doi: 10.1007/s11845-011-0673-9. Epub 2011 Jan 29.

PMID:
21279462
4.

Performance of the Framingham and SCORE cardiovascular risk prediction functions in a non-diabetic population of a Spanish health care centre: a validation study.

Barroso LC, Muro EC, Herrera ND, Ochoa GF, Hueros JI, Buitrago F.

Scand J Prim Health Care. 2010 Dec;28(4):242-8. doi: 10.3109/02813432.2010.518407. Epub 2010 Sep 27.

5.

Comparison of cardiovascular risk assessment algorithms to determine eligibility for statin therapy: implications for practice in Canada.

Mancini GB, Ryomoto A.

Can J Cardiol. 2014 Jun;30(6):661-6. doi: 10.1016/j.cjca.2014.04.001. Epub 2014 Apr 3.

PMID:
24882538
6.

Global cardiovascular risk in patients with HIV infection: concordance and differences in estimates according to three risk equations (Framingham, SCORE, and PROCAM).

Knobel H, Jericó C, Montero M, Sorli ML, Velat M, Guelar A, Saballs P, Pedro-Botet J.

AIDS Patient Care STDS. 2007 Jul;21(7):452-7.

PMID:
17651026
7.

Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events.

Pursnani A, Massaro JM, D'Agostino RB Sr, O'Donnell CJ, Hoffmann U.

JAMA. 2015 Jul 14;314(2):134-41. doi: 10.1001/jama.2015.7515.

8.

Consequences of using different methods to assess cardiovascular risk in primary care.

Fornasini M, Brotons C, Sellarès J, Martinez M, Galán ML, Sáenz I, da Pena JM.

Fam Pract. 2006 Feb;23(1):28-33. Epub 2005 Oct 21.

PMID:
16243952
9.

[Cardiovascular risk of SCORE compared to Framingham. Consequences of the change proposed by the European Societies].

Maiques Galán A, Antón García F, Franch Taix M, Albert Ros X, Aleixandre Martí E, Collado Gil A.

Med Clin (Barc). 2004 Nov 20;123(18):681-5. Spanish.

PMID:
15563814
10.

[Estimating cardiovascular risk in Spain using different algorithms].

Comín E, Solanas P, Cabezas C, Subirana I, Ramos R, Gené-Badía J, Cordón F, Grau M, Cabré-Vila JJ, Marrugat J.

Rev Esp Cardiol. 2007 Jul;60(7):693-702. Spanish.

11.

[Comparison of the SCORE function chart and the Framingham-REGICOR equation to estimate the cardiovascular risk in an urban population after 10 years of follow-up].

Buitrago Ramírez F, Cañón Barroso L, Díaz Herrera N, Cruces Muro E, Bravo Simón B, Pérez Sánchez I.

Med Clin (Barc). 2006 Sep 16;127(10):368-73. Spanish.

PMID:
16987481
12.

Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2.

Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, Sheikh A, Brindle P.

BMJ. 2008 Jun 28;336(7659):1475-82. doi: 10.1136/bmj.39609.449676.25. Epub 2008 Jun 23.

13.

Performance of Framingham cardiovascular risk scores by ethnic groups in New Zealand: PREDICT CVD-10.

Riddell T, Wells S, Jackson R, Lee AW, Crengle S, Bramley D, Ameratunga S, Pylypchuk R, Broad J, Marshall R, Kerr A.

N Z Med J. 2010 Feb 19;123(1309):50-61.

PMID:
20186242
14.

Characterization of metabolically healthy obese Brazilians and cardiovascular risk prediction.

Pimentel Ade C, Scorsatto M, de Oliveira GM, Rosa G, Luiz RR.

Nutrition. 2015 Jun;31(6):827-33. doi: 10.1016/j.nut.2014.12.024. Epub 2015 Jan 10.

PMID:
25933489
15.

Comparison of cardiovascular risk assessment tools and their guidelines in evaluation of 10-year CVD risk and preventive recommendations: A population based study.

Motamed N, Rabiee B, Perumal D, Poustchi H, Miresmail SJ, Farahani B, Maadi M, Saeedian FS, Ajdarkosh H, Khonsari MR, Hemasi GR, Zamani F.

Int J Cardiol. 2017 Feb 1;228:52-57. doi: 10.1016/j.ijcard.2016.11.048. Epub 2016 Nov 10.

PMID:
27863362
16.

Therapeutic implications of selecting the SCORE (European) versus the D'AGOSTINO (American) risk charts for cardiovascular risk assessment in hypertensive patients.

Gómez-Marcos MA, Martínez-Salgado C, Martin-Cantera C, Recio-Rodríguez JI, Castaño-Sánchez Y, Giné-Garriga M, Rodriguez-Sanchez E, García-Ortiz L.

BMC Cardiovasc Disord. 2009 May 11;9:17. doi: 10.1186/1471-2261-9-17.

17.

Detection of high-risk young adults and women by coronary calcium and National Cholesterol Education Program Panel III guidelines.

Nasir K, Michos ED, Blumenthal RS, Raggi P.

J Am Coll Cardiol. 2005 Nov 15;46(10):1931-6. Epub 2005 Oct 20.

18.

Risk estimates of cardiovascular diseases in a Sri Lankan community.

Ranawaka UK, Wijekoon CN, Pathmeswaran A, Kasturiratne A, Gunasekera D, Chackrewarthy S, Kato N, Wickramasinghe AR.

Ceylon Med J. 2016 Mar;61(1):11-7. doi: 10.4038/cmj.v61i1.8253.

19.

Comparison of methods to identify individuals at increased risk of cardiovascular disease in Italian cohorts.

Giavarina D, Barzon E, Cigolini M, Mezzena G, Soffiati G.

Nutr Metab Cardiovasc Dis. 2007 May;17(4):311-8. Epub 2006 Mar 20.

PMID:
17434054
20.

Sex related cardiovascular risk stratification based on quantification of atherosclerosis and inflammation.

Erbel R, Möhlenkamp S, Lehmann N, Schmermund A, Moebus S, Stang A, Grönemeyer D, Seibel R, Mann K, Volbracht L, Dragano N, Siegrist J, Jöckel KH; Heinz Nixdorf Recall Study Investigative Group.

Atherosclerosis. 2008 Apr;197(2):662-72. Epub 2007 Mar 26.

PMID:
17386928

Supplemental Content

Support Center